Biovail Company Profile

06:22 EST 23rd November 2017 | BioPortfolio

Biovail Corporation is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company's therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease (including Type II diabetes). Biovail drives business growth by commercializing these products both directly through its own sales and marketing divisions and/or through strategic partners. Biovail's core competency lies in the development and large-scale manufacturing of pharmaceutical products incorporating oral drug-delivery technologies. Biovail has a broad portfolio of proprietary drug-delivery technologies that represent the foundation upon which the Company's strategy is based. Product candidates that meet a rigorous screening process are considered for addition to the Company's development pipeline. To this end, development efforts are currently ongoing for a number of pipeline products, including a once-daily formulation of carvedilol, novel formulations of bupropion and venlafaxine, separate combination products involving bupropion and tramadol, and a number of feasibility, or earlier-stage programs.


7150 Mississauga Road
L5N 8M5


Phone: 905.286.3000
Fax: 905.286.3050

News Articles [7 Associated News Articles listed on BioPortfolio]

Parkinson Partners, PTV News: Jun 03, 2010

Biovail and Kyowa Hakko Kirin hook up in drug development deal

PTV News: Sep 2, 2009

Top stories on September 2nd, 2009: Pfizer set to pay US$2.3 B to settle charges of illegal drugs promotion Biovail Parkinson's psychosis drug fails FDA says E-cigarettes not ...

News Headlines, PTV News: Feb 11, 2010

Animal health: Sanofi-Aventis plans US$ 20B tie-up with Merck Alexza and BioVail in inhalable antipsychotic deal Vioxx closure: final settlement for the last lawsuits [RELEASED 11:00]

Deep breaths, PTV News: Feb 11, 2010

Deep breaths: Alexza and Biovail sign US$ 130M deal to develop inhalable anti-psychotic [RELEASED 14:30]

News Headlines, PTV News: Jun 03, 2010

Today's forthcoming news stories: Positive late stage trial results for Novartis’ pancreatic cancer drug; France joins European drive to slash drug costs, and Biovail in Japanese hook-up to develop...

Maricann Announces Appointment of New Chief Financial Officer

TORONTO, ONTARIO -- (Marketwired) -- 10/03/17 -- Maricann Group Inc. (CSE: MARI)(CSE: MARI.CN)(CNSX: MARI)(OTCQB: MRRCF)(FRANKFURT: 75M) ("Maricann" or the "Company") is pleased to announce the appo...

Enanta Pharmaceuticals Announces the Appointment of Kristine Peterson to Its Board of Directors

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the appointment of Kristine Peterson to its Board of Directors. Ms. Peterson will also serve as a member of the Compensa...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Ativan [BTA Pharmaceuticals Inc.]

Ativan    CIV (lorazepam) Tablets

Isordil [BTA Pharmaceuticals, Inc.]

Isordil Titradose™ (isosorbide dinitrate)Tablets


Ativan [Cardinal Health]

Ativan    CIV (lorazepam) Tablets

PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

The objective of this study is to evaluate the comparative bioavailability between bupropion hydrochloride 300 mg extended release tablets (Teva Pharmaceuticals USA) and Wellbutrin XL® 30...

Companies [6 Associated Companies listed on BioPortfolio]

Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products...


Biovail Corporation is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company's therapeutic areas of focus ...

Concerned Shareholders of Biovail

Valeant Pharmaceuticals International & Biovail Corporation

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACA...

More Information about "Biovail" on BioPortfolio

We have published hundreds of Biovail news stories on BioPortfolio along with dozens of Biovail Clinical Trials and PubMed Articles about Biovail for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biovail Companies in our database. You can also find out about relevant Biovail Drugs and Medications on this site too.

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Corporate Database Quicklinks

Searches Linking to this Company Record